These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27578295)

  • 1. In Vitro Functional Characterisation of Cytochrome P450 (CYP) 2C19 Allelic Variants CYP2C19*23 and CYP2C19*24.
    Lau PS; Leong KV; Ong CE; Dong AN; Pan Y
    Biochem Genet; 2017 Feb; 55(1):48-62. PubMed ID: 27578295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of CYP2C19*18 and CYP2C19*19 alleles on omeprazole 5-hydroxylation: in vitro functional analysis of recombinant enzymes expressed in Saccharomyces cerevisiae.
    Hanioka N; Tsuneto Y; Saito Y; Maekawa K; Sawada J; Narimatsu S
    Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):388-93. PubMed ID: 18312490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Molecular and Enzyme Kinetic Basis for Altered Activity of Three Cytochrome P450 2C19 Variants Found in the Chinese Population.
    Dong AN; Ahemad N; Pan Y; Palanisamy UD; Yiap BC; Ong CE
    Curr Mol Pharmacol; 2020; 13(3):233-244. PubMed ID: 31713493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNA and protein expression of dog liver cytochromes P450 in relation to the metabolism of human CYP2C substrates.
    Graham MJ; Bell AR; Crewe HK; Moorcraft CL; Walker L; Whittaker EF; Lennard MS
    Xenobiotica; 2003 Mar; 33(3):225-37. PubMed ID: 12637241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of new CYP2C19 variants exhibiting decreased enzyme activity in the metabolism of S-mephenytoin and omeprazole.
    Lee SJ; Kim WY; Kim H; Shon JH; Lee SS; Shin JG
    Drug Metab Dispos; 2009 Nov; 37(11):2262-9. PubMed ID: 19661214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the effects of 20 nonsynonymous single nucleotide polymorphisms of CYP2C19 on S-mephenytoin 4'-hydroxylation and omeprazole 5'-hydroxylation.
    Wang H; An N; Wang H; Gao Y; Liu D; Bian T; Zhu J; Chen C
    Drug Metab Dispos; 2011 May; 39(5):830-7. PubMed ID: 21325430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidation of R- and S-omeprazole stereoselectively mediated by liver microsomal cytochrome P450 2C19 enzymes from cynomolgus monkeys and common marmosets.
    Uehara S; Kawano M; Murayama N; Uno Y; Utoh M; Inoue T; Sasaki E; Yamazaki H
    Biochem Pharmacol; 2016 Nov; 120():56-62. PubMed ID: 27641812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-Directed Mutagenesis of Cytochrome P450 2D6 and 2C19 Enzymes: Expression and Spectral Characterization of Naturally Occurring Allelic Variants.
    Dong AN; Pan Y; Palanisamy UD; Yiap BC; Ahemad N; Ong CE
    Appl Biochem Biotechnol; 2018 Sep; 186(1):132-144. PubMed ID: 29524040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
    Lasker JM; Wester MR; Aramsombatdee E; Raucy JL
    Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of CYP2C19 polymorphism on serum levels of vitamin B12 in patients on long-term omeprazole treatment.
    Sagar M; Janczewska I; Ljungdahl A; Bertilsson L; Seensalu R
    Aliment Pharmacol Ther; 1999 Apr; 13(4):453-8. PubMed ID: 10215728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of two novel CYP2C19 variants (CYP2C19*18 and CYP2C19*19) found in a Japanese population.
    Hanioka N; Tsuneto Y; Saito Y; Sumada T; Maekawa K; Saito K; Sawada J; Narimatsu S
    Xenobiotica; 2007 Apr; 37(4):342-55. PubMed ID: 17455109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlorpropamide 2-hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro: chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphism.
    Shon JH; Yoon YR; Kim MJ; Kim KA; Lim YC; Liu KH; Shin DH; Lee CH; Cha IJ; Shin JG
    Br J Clin Pharmacol; 2005 May; 59(5):552-63. PubMed ID: 15842554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxylation index of omeprazole in relation to CYP2C19 polymorphism and sex in a healthy Iranian population.
    Payan M; Rouini MR; Tajik N; Ghahremani MH; Tahvilian R
    Daru; 2014 Dec; 22(1):81. PubMed ID: 25498969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of CYP2C19 variants in nebivolol 4-hydroxlation in vitro.
    Zhou XY; Hu XX; Li MF; Wang H; Zhang LQ; Hu GX; Cai JP
    Drug Test Anal; 2018 May; 10(5):807-813. PubMed ID: 29098786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Marmoset Cytochrome P450 2C19 in Livers Efficiently Metabolizes Human P450 2C9 and 2C19 Substrates, S-Warfarin, Tolbutamide, Flurbiprofen, and Omeprazole.
    Uehara S; Uno Y; Inoue T; Kawano M; Shimizu M; Toda A; Utoh M; Sasaki E; Yamazaki H
    Drug Metab Dispos; 2015 Oct; 43(10):1408-16. PubMed ID: 26228688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human CYP1A1 variants lead to differential eicosapentaenoic acid metabolite patterns.
    Schwarz D; Kisselev P; Chernogolov A; Schunck WH; Roots I
    Biochem Biophys Res Commun; 2005 Oct; 336(3):779-83. PubMed ID: 16153604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes.
    Karam WG; Goldstein JA; Lasker JM; Ghanayem BI
    Drug Metab Dispos; 1996 Oct; 24(10):1081-7. PubMed ID: 8894508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro modulatory effects of Andrographis paniculata, Centella asiatica and Orthosiphon stamineus on cytochrome P450 2C19 (CYP2C19).
    Pan Y; Abd-Rashid BA; Ismail Z; Ismail R; Mak JW; Pook PC; Er HM; Ong CE
    J Ethnopharmacol; 2011 Jan; 133(2):881-7. PubMed ID: 21093571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and functional characterization of new potentially defective alleles of human CYP2C19.
    Blaisdell J; Mohrenweiser H; Jackson J; Ferguson S; Coulter S; Chanas B; Xi T; Ghanayem B; Goldstein JA
    Pharmacogenetics; 2002 Dec; 12(9):703-11. PubMed ID: 12464799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of CYP2C19 variants on methadone metabolism in vitro.
    Lan T; Yuan LJ; Hu XX; Zhou Q; Wang J; Huang XX; Dai DP; Cai JP; Hu GX
    Drug Test Anal; 2017 Apr; 9(4):634-639. PubMed ID: 27199033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.